IRadimed Corporation (IRMD)

IRadimed Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	553	598	356	570	280	269
Market Cap Growth	12.41%	68.32%	-37.67%	103.87%	4.18%	0.39%
Enterprise Value	510	551	300	510	230	225
PE Ratio	30.97	34.81	27.71	61.16	204.34	27.88
PS Ratio	8.17	9.13	6.67	13.64	8.82	6.97
PB Ratio	7.27	8.38	4.83	7.90	4.56	4.84
P/FCF Ratio	51.34	109.64	43.53	54.23	54.00	27.55
P/OCF Ratio	43.54	44.44	35.40	50.66	48.09	26.24
EV/Sales Ratio	7.53	8.40	5.62	12.20	7.27	5.85
EV/EBITDA Ratio	21.75	24.47	17.79	45.39	319.25	21.90
EV/EBIT Ratio	22.53	25.33	18.52	51.88	-373.63	24.90
EV/FCF Ratio	47.33	100.89	36.70	48.52	44.49	23.11
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.05
Debt / EBITDA Ratio	0.08	0.09	0.13	0.22	3.76	0.29
Debt / FCF Ratio	0.18	0.37	0.27	0.24	0.52	0.30
Quick Ratio	7.64	3.80	8.33	9.91	11.50	9.14
Current Ratio	9.44	4.66	9.06	11.18	12.96	10.06
Asset Turnover	0.78	0.78	0.68	0.54	0.46	0.64
Return on Equity (ROE)	24.60%	24.60%	18.90%	13.90%	2.30%	19.30%
Return on Assets (ROA)	20.50%	20.40%	16.40%	12.10%	2.00%	16.00%
Return on Capital (ROIC)	21.08%	21.57%	16.33%	12.47%	-1.18%	15.75%
Earnings Yield	3.24%	2.87%	3.61%	1.64%	0.49%	3.59%
FCF Yield	1.95%	0.91%	2.30%	1.84%	1.85%	3.63%
Dividend Yield	0.34%	3.50%	3.50%	0.00%	0.00%	0.00%
Payout Ratio	10.64%	123.50%	98.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-0.50%	-0.69%	-0.36%	-0.61%	-1.94%	-1.37%
Total Shareholder Return	-0.16%	2.81%	3.14%	-0.61%	-1.94%	-1.37%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).